HOME › DRUGS › PANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)
ACTIVE SUBSTANCE / INN

PANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)

Brand name(s): Foclivia
EMA LISTED
AUTHORISED
Influenza, Human;Immunization;Disease Outbreaks
ACTIVE SUBSTANCE
Pandemic Influenza Vaccine (H5N1) (Surface Antigen, Inactivated, Adjuvanted)
REGULATORS
EMA
SPONSORS / MAH
Seqirus S.r.l. 
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
FocliviaSeqirus S.r.l. Authorised18/10/2009Influenza, Human;Immunization;Disease Outbreaks

FULL INTELLIGENCE ON PANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →